Literature DB >> 33912310

Management and outcome of hypertrophic obstructive cardiomyopathy in pregnant women: a case report.

Maryem Assamti1, Ramia Bougrine1, Nabila Ismaili2, Noha El Ouafi1,2.   

Abstract

Hypertrophic cardiomyopathy (HCM) is a common inherited cardiomyopathy, with an estimated prevalence of 1 in 500 people. Despite overall favorable outcomes with modern treatment and early diagnosis of disease, adverse complications could occur during times of physiological stress like pregnancy. Complications of HCM include sudden cardiac death, heart failure, and arrhythmia. We report the case of a 32-year-old pregnant woman with obstructive HCM, presenting with recurrent episodes of ventricular arrhythmia despite medical therapy. This case exhibits how close monitoring and proper management during pregnancy according to the latest recommendations, resulted in a successful and uneventful delivery. Copyright: Maryem Assamti et al.

Entities:  

Keywords:  Hypertrophic cardiomyopathy; case report; pregnancy; sudden cardiac death

Mesh:

Year:  2021        PMID: 33912310      PMCID: PMC8052611          DOI: 10.11604/pamj.2021.38.140.25699

Source DB:  PubMed          Journal:  Pan Afr Med J


  12 in total

1.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

2.  Cardiovascular events in pregnancy with hypertrophic cardiomyopathy.

Authors:  Hiroaki Tanaka; Chizuko Kamiya; Shinji Katsuragi; Kayo Tanaka; Takekazu Miyoshi; Mitsuhiro Tsuritani; Masashi Yoshida; Naoko Iwanaga; Reiko Neki; Jun Yoshimatsu; Tomoaki Ikeda
Journal:  Circ J       Date:  2014-08-06       Impact factor: 2.993

3.  B-type natriuretic peptide in pregnant women with heart disease.

Authors:  David Tanous; Samuel C Siu; Jennifer Mason; Matthias Greutmann; Rachel M Wald; John D Parker; Mathew Sermer; Jack M Colman; Candice K Silversides
Journal:  J Am Coll Cardiol       Date:  2010-10-05       Impact factor: 24.094

4.  Yield of genetic testing in hypertrophic cardiomyopathy.

Authors:  Sara L Van Driest; Steve R Ommen; A Jamil Tajik; Bernard J Gersh; Michael J Ackerman
Journal:  Mayo Clin Proc       Date:  2005-06       Impact factor: 7.616

5.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).

Authors:  Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

6.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Authors:  Perry M Elliott; Aris Anastasakis; Michael A Borger; Martin Borggrefe; Franco Cecchi; Philippe Charron; Albert Alain Hagege; Antoine Lafont; Giuseppe Limongelli; Heiko Mahrholdt; William J McKenna; Jens Mogensen; Petros Nihoyannopoulos; Stefano Nistri; Petronella G Pieper; Burkert Pieske; Claudio Rapezzi; Frans H Rutten; Christoph Tillmanns; Hugh Watkins
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

7.  Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States.

Authors:  Martin S Maron; Jennifer L Hellawell; Jaime C Lucove; Ramin Farzaneh-Far; Iacopo Olivotto
Journal:  Am J Cardiol       Date:  2016-03-02       Impact factor: 2.778

8.  2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

Authors:  Vera Regitz-Zagrosek; Jolien W Roos-Hesselink; Johann Bauersachs; Carina Blomström-Lundqvist; Renata Cífková; Michele De Bonis; Bernard Iung; Mark Richard Johnson; Ulrich Kintscher; Peter Kranke; Irene Marthe Lang; Joao Morais; Petronella G Pieper; Patrizia Presbitero; Susanna Price; Giuseppe M C Rosano; Ute Seeland; Tommaso Simoncini; Lorna Swan; Carole A Warnes
Journal:  Eur Heart J       Date:  2018-09-07       Impact factor: 29.983

9.  Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC).

Authors:  S Goland; I M van Hagen; G Elbaz-Greener; U Elkayam; A Shotan; W M Merz; S C Enar; I R Gaisin; P G Pieper; M R Johnson; R Hall; A Blatt; J W Roos-Hesselink
Journal:  Eur Heart J       Date:  2017-09-14       Impact factor: 29.983

10.  Risk associated with pregnancy in hypertrophic cardiomyopathy.

Authors:  Camillo Autore; Maria Rosa Conte; Marco Piccininno; Paola Bernabò; Giovanna Bonfiglio; Paolo Bruzzi; Paolo Spirito
Journal:  J Am Coll Cardiol       Date:  2002-11-20       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.